Skip to Content

M 66 (Meloxicam 7.5 mg)

Pill with imprint M 66 is Yellow, Round and has been identified as Meloxicam 7.5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Meloxicam is used in the treatment of osteoarthritis; juvenile rheumatoid arthritis; rheumatoid arthritis; pain and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Meloxicam 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 66

Meloxicam 7.5 mg M 66
Meloxicam 7.5 mg M 66
Meloxicam 7.5 mg M 66

Meloxicam

Imprint:
M 66
Strength:
7.5 mg
Color:
Yellow
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory drugs
Pregnancy Category:
C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
00378-1066 Mylan Pharmaceuticals Inc.
51079-0457 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide